Inner Logic Raises $11.5M Seed

Inner Logic Raises $11.5M Seed

Inner Logic, based in Baltimore, Maryland, is a medical technology company providing simulation infrastructure for the development and testing of procedural devices. The company recently announced it has raised $11.5 million in a seed funding round.

This round was co-led by General Catalyst and Bison Ventures, with participation from J2VP, Defined, PTX, Valia Ventures, Page One, Alumni Ventures, and Flare.

Inner Logic intends to use the capital to build autonomy-enabling infrastructure for procedural medical devices, moving development and testing into simulation environments to improve surgical outcomes and enable the development of autonomous systems.

Founded in 2026, Inner Logic was established by CEO Tito Porras, MD, CTO Mathias Unberath, PhD, and Chief Robotics Officer Axel Krieger, PhD. The company provides a simulation platform that allows device manufacturers to test and validate procedural devices across thousands of virtual patients grounded in real clinical data, aiming to reduce dependence on physical testing and facilitate the advancement of intelligent, autonomous surgical systems.

Funding Details

Company Website: https://innerlogic.io/

Company: Inner Logic

Raised: $11.5M

Round: Seed

Funding Date: July 22, 2026

Lead Investor: General Catalyst, Bison Ventures

Additional Investors: J2VP, Defined, PTX, Valia Ventures, Page One, Alumni Ventures, Flare

Company Website: https://innerlogic.io/

Software Category: Health Technology